β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction

CONCLUSIONS: Use of β-blockers was significantly associated with worse prognosis specifically in patients with HFpEF and high CFS, but not in those with low CFS. Use of β-blockers in HFpEF patients with frailty may need careful attention.PMID:38019285 | DOI:10.1007/s00392-023-02301-5
Source: Clin Med Res - Category: Research Authors: Source Type: research